Radiopharmaceuticals

New York, United States, November 9, 2026 Actinium Pharmaceuticals, Inc. has announced the formation of a new Scientific Advisory...

Melbourne, Australia, and Indianapolis, Indiana, United States, November 5, 2026 Telix Pharmaceuticals Limited has announced its participation in Thera4Care,...

Berlin, Germany, November 4, 2026 Pentixapharm Holding AG has announced significant progress in preparations for its pivotal Phase 3...

BOSTON, Mass. — September 27, 2026 ITM Isotope Technologies Munich SE and Lumara Bio announced new real-world re-treatment and...

Melbourne, Australia; Indianapolis, U.S.; Munich, Germany, September 21, 2026 Telix Pharmaceuticals Limited has announced a strategic agreement to lead...

MELBOURNE, Australia and INDIANAPOLIS, Ind. — September 14, 2026 Telix Pharmaceuticals announced that the U.S. Food and Drug Administration...

BOSTON, Mass. — September 14, 2026 Curium™ announced that the U.S. Food and Drug Administration (FDA) has approved its...

Boston, Massachusetts, U.S., and Vancouver, British Columbia, Canada, September 8, 2026 Alpha-9 Oncology has announced the dosing of the...

Melbourne, Australia and Indianapolis, Indiana, U.S. | August 20, 2026 Telix Pharmaceuticals reported strong first-half 2026 performance, highlighting continued...

Uppsala and Garching/Munich, August 20, 2026 Akiram Therapeutics has entered into a Lutetium-177 (Lu-177) supply agreement with ITM Isotope...